In addition to Slamf7 staining, Slamf6 and Nkg2d immunostaining were more spread out in ST-5-002-treated mice compared with those in mice that did not receive isoxazole treatment, which were more restricted to non-tumor regions (Fig. 6j). This evidence concerns the gene KLRK1 and neoplasm.